Novartis is contesting a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusively patenting known medicines in Indian Supreme Court. If successful, the move would have a devastating impact on access to affordable medicines across the developing world, according to international humanitarian medical organisation Médecins Sans Frontières (MSF).
To learn more, visit: msfaccess.org/novartis-drop-the-case
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?